| Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry GW Canonica, GL Colombo, GM Bruno, S Di Matteo, C Martinotti, F Blasi, ... World Allergy Organization Journal 12 (1), 100007, 2019 | 114 | 2019 |
| Probiotic therapy with VSL# 3® in patients with NAFLD: a randomized clinical trial G Derosa, L Guasti, A D’Angelo, C Martinotti, MC Valentino, S Di Matteo, ... Frontiers in nutrition 9, 846873, 2022 | 20 | 2022 |
| Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review GL Colombo, S Di Matteo, C Martinotti, M Oselin, MC Valentino, ... Therapeutic Advances in Respiratory Disease 13, 1753466619841350, 2019 | 18 | 2019 |
| Omalizumab for severe allergic asthma treatment in Italy: a cost-effectiveness analysis from PROXIMA study GW Canonica, GL Colombo, P Rogliani, P Santus, C Pitotti, S Di Matteo, ... Risk management and healthcare policy, 43-53, 2020 | 13 | 2020 |
| Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative GL Colombo, S Di Matteo, C Martinotti, SM Jugl, P Gunda, M Naclerio, ... ClinicoEconomics and Outcomes Research, 477-491, 2018 | 11 | 2018 |
| Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes E Torre, GM Bruno, S Di Matteo, C Martinotti, M Oselin, MC Valentino, ... ClinicoEconomics and Outcomes Research, 413-421, 2018 | 10 | 2018 |
| Economic evaluation of dulaglutide vs traditional therapies: Implications of the outcomes of the rewind study E Torre, GM Bruno, S Di Matteo, C Martinotti, MC Valentino, LC Bottaro, ... ClinicoEconomics and Outcomes Research, 177-189, 2020 | 9 | 2020 |
| Economic impact of COVID-19 lockdown on Italian NHS: focus on diabetes mellitus E Torre, GL Colombo, S Di Matteo, C Martinotti, MC Valentino, A Rebora, ... ClinicoEconomics and Outcomes Research, 503-518, 2021 | 8 | 2021 |
| The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis GL Colombo, S Di Matteo, C Martinotti, M Oselin, GM Bruno, GM Beghi ClinicoEconomics and Outcomes Research, 75-82, 2018 | 8 | 2018 |
| Vitamin D3 supplementation improves glycemic control in type 2 diabetic patients: results from an Italian clinical trial G Derosa, A D’Angelo, C Martinotti, MC Valentino, S Di Matteo, GM Bruno, ... International Journal for Vitamin and Nutrition Research, 2020 | 7 | 2020 |
| Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives E Torre, S Di Matteo, GM Bruno, C Martinotti, MC Valentino, G Testino, ... ClinicoEconomics and Outcomes Research, 607-618, 2022 | 2 | 2022 |
| Cost-utility analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and insulin glargine: economic implications of the outcomes of the CVD-real studies I and II E Torre, GM Bruno, S Di Matteo, C Martinotti, MC Valentino, LC Bottaro, ... Health Services Insights 13, 1178632920929982, 2020 | 2 | 2020 |
| Economic impact of oral corticosteroids in severe asthmatics: a simulation study in selected European countries A Bourdin, EH Bel, B Dahlén, R Djukanovic, E Heffler, P Kuna, R Louis, ... European Respiratory Journal 60 (suppl 66), 2022 | 1 | 2022 |
| L’iperuricemia cronica con e senza deposito di urato S Carugo, M Cozzolino, C Esposito, D Lauri, S Lucreziotti, F Oliva, ... CLINICO ECONOMICS 2020 (Supplemento 1), 1-17, 2020 | 1 | 2020 |
| Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma E Heffler, C Sirena, M Ferrando, S Di Matteo, C Martinotti, GM Bruno, ... Allergy 73, 528-528, 2018 | 1 | 2018 |
| Economic impact of metabolic dysfunction-associated steatotic liver (MASLD) in Italy. Analysis and perspectives E Torre, S Di Matteo, C Martinotti, U Goglia, GM Bruno, G Testino, ... | | 2024 |
| EE211 Shadow Costs of Systemic Corticosteroid-Related Adverse Events in Ulcerative Colitis: A Pharmacoeconomic Evaluation GL Colombo, S Di Matteo, G Bruno, C Martinotti, MC Valentino, E Visentin Value in Health 25 (12), S94, 2022 | | 2022 |
| EE668 Empagliflozin for the Treatment of Adult Patients With Symptomatic Chronic Heart Failure With Reduced Ejection Fraction (HFREF): A Cost-Effectiveness Analysis From the … GL Colombo, S Di Matteo, G Bruno, C Martinotti, S Linden Value in Health 25 (12), S188, 2022 | | 2022 |
| EE281 Freestyle Libre 2 Flash Glucose Monitoring System: Budget Impact and Cost-Utility Analyses in Type 1 Diabetes From the Italian NHS Perspective GL Colombo, E Torre, S Di Matteo, E Monti, C Martinotti, G Bruno, ... Value in Health 25 (12), S108-S109, 2022 | | 2022 |
| EE160 Budget Impact Analysis for Point of Care Testing (POCT) in Diabetic Patient Monitoring: The Experience of an Italian Local Health Board (ASL3 Genoa, Italy) E Torre, A Spitaleri, S Di Matteo, G Bruno, C Martinotti, A Ciccarone, ... Value in Health 25 (12), S84, 2022 | | 2022 |
